| |
EGFRvIII expression
| |
|---|
| |
Total
|
Negative or low
|
High
|
P-value
|
|---|
|
Staging
| | | | |
|
T classification#
|
108
| | | |
|
1
|
38
|
35
|
3
|
<0.001
|
|
2
|
36
|
20
|
16
| |
|
3
|
6
|
4
|
2
| |
|
4
|
28
|
15
|
13
| |
|
N classification
|
108
| | | |
|
0
|
72
|
53
|
19
|
0.071
|
|
1
|
15
|
11
|
4
| |
|
2
|
21
|
10
|
11
| |
|
TNM stage
|
108
| | | |
|
1
|
30
|
29
|
1
|
<0.001
|
|
2
|
24
|
13
|
11
| |
|
3
|
13
|
10
|
3
| |
|
4
|
41
|
22
|
19
| |
|
Factors
| | | | |
|
EGFR GCN amplification
|
104
| | | |
|
Negative
|
53
|
38
|
15
|
0.529
|
|
Positive
|
51
|
33
|
18
| |
|
EGFR expression
|
108
| | | |
|
Negative
|
39
|
27
|
12
|
1.000
|
|
Positive
|
69
|
47
|
22
| |
|
PIK3CA GCN increase
|
105
| |
1.000
| |
|
Negative
|
79
|
53
|
26
| |
|
Positive
|
26
|
18
|
8
| |
|
PTEN expression
|
108
| | | |
|
Negative
|
53
|
41
|
12
|
0.064
|
|
Positive
|
55
|
33
|
22
| |
|
pAKT expression#
|
107
| | | |
|
Negative
|
14
|
11
|
3
|
0.543
|
|
Positive
|
93
|
63
|
30
| |
- P-value was estimated using chi-square method or #Fisher’s exact test.
